Terms: = Liver cancer AND RAD51B, ENSG00000182185, 5890, RAD51L1, O15315, hREC2, R51H2, REC2, MGC34245 AND Treatment
4 results:
1. Proton beam therapy for hepatocellular carcinoma with bile duct invasion.
Iizumi T; Okumura T; Hasegawa N; Ishige K; Fukuda K; Seo E; Makishima H; Niitsu H; Takahashi M; Sekino Y; Takahashi H; Takizawa D; Oshiro Y; Baba K; Murakami M; Saito T; Numajiri H; Mizumoto M; Nakai K; Sakurai H
BMC Gastroenterol; 2023 Aug; 23(1):267. PubMed ID: 37537527
[TBL] [Abstract] [Full Text] [Related]
2. LiSNet: An artificial intelligence -based tool for liver imaging staging of hepatocellular carcinoma aggressiveness.
Sun SW; Xu X; Liu QP; Chen JN; Zhu FP; Liu XS; Zhang YD; Wang J
Med Phys; 2022 Nov; 49(11):6903-6913. PubMed ID: 36134900
[TBL] [Abstract] [Full Text] [Related]
3. Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial.
Rozeman EA; Menzies AM; van Akkooi ACJ; Adhikari C; Bierman C; van de Wiel BA; Scolyer RA; Krijgsman O; Sikorska K; Eriksson H; Broeks A; van Thienen JV; Guminski AD; Acosta AT; Ter Meulen S; Koenen AM; Bosch LJW; Shannon K; Pronk LM; Gonzalez M; Ch'ng S; Grijpink-Ongering LG; Stretch J; Heijmink S; van Tinteren H; Haanen JBAG; Nieweg OE; Klop WMC; Zuur CL; Saw RPM; van Houdt WJ; Peeper DS; Spillane AJ; Hansson J; Schumacher TN; Long GV; Blank CU
Lancet Oncol; 2019 Jul; 20(7):948-960. PubMed ID: 31160251
[TBL] [Abstract] [Full Text] [Related]
4. Toward the proteomic identification of biomarkers for the prediction of HBV related hepatocellular carcinoma.
He QY; Zhu R; Lei T; Ng MY; Luk JM; Sham P; Lau GK; Chiu JF
J Cell Biochem; 2008 Feb; 103(3):740-52. PubMed ID: 17557278
[TBL] [Abstract] [Full Text] [Related]
